MCID: MCR191
MIFTS: 45

Microscopic Colitis malady

Categories: Gastrointestinal diseases, Rare diseases

Aliases & Classifications for Microscopic Colitis

About this section
Sources:
10Disease Ontology, 12DISEASES, 51Orphanet, 36MeSH, 65UMLS, 42NCIt, 59SNOMED-CT, 66UMLS via Orphanet, 28ICD10 via Orphanet, 37MESH via Orphanet
See all MalaCards sources

Aliases & Descriptions for Microscopic Colitis:

Name: Microscopic Colitis 10 12 51
 
Colitis, Microscopic 36 65

Characteristics:

Orphanet epidemiological data:

51
microscopic colitis:
Prevalence: 1-9/100000 (Europe); Age of onset: Adult; Age of death: normal life expectancy

Classifications:



External Ids:

Disease Ontology10 DOID:0060182
MeSH36 D046728
NCIt42 C38504
Orphanet51 58220
SNOMED-CT59 235753003
UMLS via Orphanet66 C0400821
ICD10 via Orphanet28 K52.8
MESH via Orphanet37 D046728
UMLS65 C0400821

Summaries for Microscopic Colitis

About this section
Wikipedia:68 Microscopic colitis refers to two related medical conditions which cause diarrhea: collagenous colitis... more...

MalaCards based summary: Microscopic Colitis, also known as colitis, microscopic, is related to meckel's diverticulum and collagenous colitis. An important gene associated with Microscopic Colitis is CD79A (CD79a Molecule), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and SIDS Susceptibility Pathways. Affiliated tissues include colon, lung and liver, and related mouse phenotypes are renal/urinary system and tumorigenesis.

Disease Ontology:10 A colitis that can only be diagnosed by the examination of colon tissue under a microscope.

Related Diseases for Microscopic Colitis

About this section

Diseases related to Microscopic Colitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 435)
idRelated DiseaseScoreTop Affiliating Genes
1meckel's diverticulum30.4CD79A, LYZ
2collagenous colitis29.8CD79A, HLA-DRB1, IFNG, IL2, IL4, IL6
3viral hepatitis29.6HLA-DRB1, IFNG, TNF
4capillary hemangioma29.4CD79A, IFNG, IL4
5hypoglycemia29.2IFNG, IL2, IL4
6renal cell carcinoma29.0IFNG, IL2, IL6, TNF
7systemic lupus erythematosus28.7CD79A, HLA-DRB1, IFNG, IL2, IL6, TNF
8asthma28.6CD79A, IFNG, IL4, IL6, TNF
9lymphocytic colitis10.6
10congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome10.5HLA-DRB1, TNF
11microsomia hemifacial radial defects10.5HLA-DRB1, TNF
12autoimmune polyglandular syndrome type 210.5HLA-DRB1, TNF
13best1 retinopathy10.5HLA-DRB1, TNF
14pityriasis rosea10.5CD79A, HLA-DRB1
15androgen insensitivity syndrome, mild10.5HLA-DRB1, TNF
16drug-induced mental disorder10.4HLA-DRB1, TNF
17rhizomelic dysplasia patterson lowry type10.4HLA-DRB1, TNF
18noonan-like/multiple giant cell lesion syndrome10.4HLA-DRB1, TNF
19lymphocytic choriomeningitis10.4HLA-DRB1, TNF
20moderately severe hemophilia a10.4HLA-DRB1, TNF
21hypercalcemic sarcoidosis10.4LYZ, TNF
22rhinoscleroma10.4LYZ, TNF
23subacute glomerulonephritis10.4CD79A, LYZ
24tuberculous uveitis10.4LYZ, TNF
25crescentic glomerulonephritis10.4CD79A, LYZ
26ureterocele10.3IL2, TNF
27cogan-reese syndrome10.3CD79A, TNF
28plantar nerve lesion10.3IL6, TNF
29intermediate dend syndrome10.3IL6, TNF
30crohn's disease10.3IL6, TNF
31plasma protein metabolism disease10.3CD79A, IL6
32endometrial stromal sarcoma10.3CD79A, TNF
33malignant sertoli-leydig cell tumor of ovary10.3IL6, TNF
34cholecystitis10.3CD79A, IL2
35hemosiderosis10.3CD79A, LYZ
36mammary paget's disease10.3IL6, TNF
37inflammatory leiomyosarcoma10.3HLA-DRB1, IL6
38retinal drusen10.3CD79A, IL2
39posterior valve urethra10.3IL6, TNF
40t cell immunodeficiency primary10.3IL6, TNF
41intestinal impaction10.3CD79A, IL6
42residual stage angle-closure glaucoma10.3IL6, TNF
43precursor b lymphoblastic lymphoma/leukemia10.3IL6, TNF
44paranoid schizophrenia10.3IL6, TNF
45dysgammaglobulinemia10.3CD79A, IL4
46ischemic optic neuropathy10.3IL6, TNF
47egg allergy10.3CD79A, IL4
48primary progressive freezing gait10.3IL4, TNF
49angioid streaks10.3HLA-DRB1, IL2
50hemorrhagic fever with renal syndrome10.3HLA-DRB1, IL4

Graphical network of the top 20 diseases related to Microscopic Colitis:



Diseases related to microscopic colitis

Symptoms for Microscopic Colitis

About this section

Drugs & Therapeutics for Microscopic Colitis

About this section

Drugs for Microscopic Colitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 30)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
InfliximabapprovedPhase 4349170277-31-3
Synonyms:
Ig gamma-1 chain C region
 
Inflectra
Remicade
Remsima
2Antirheumatic AgentsPhase 4, Phase 2, Phase 38496
3Gastrointestinal AgentsPhase 46401
4Dermatologic AgentsPhase 44555
5
BudesonideapprovedPhase 3, Phase 238151333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide Inhalation
Budesonide MMX
Budesonide Nasal
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
 
Horacort
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort FLEXHALER
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Uceris
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
6glucocorticoidsPhase 3, Phase 23896
7Respiratory System AgentsPhase 3, Phase 23931
8Bronchodilator AgentsPhase 3, Phase 22377
9Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 29988
10HormonesPhase 3, Phase 211748
11Hormone AntagonistsPhase 3, Phase 210002
12Analgesics, Non-NarcoticPhase 2, Phase 35184
13AnalgesicsPhase 2, Phase 39358
14Anti-Asthmatic AgentsPhase 3, Phase 22796
15Anti-Inflammatory AgentsPhase 2, Phase 38478
16Anti-Inflammatory Agents, Non-SteroidalPhase 2, Phase 33549
17Peripheral Nervous System AgentsPhase 2, Phase 318510
18MesalaminePhase 2, Phase 315289-57-6
19
Glatiramer Acetateapproved, investigationalPhase 294147245-92-93081884
Synonyms:
(2S)-2,6-diaminohexanoic acid
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
(2S)-2-aminopentanedioic acid
(2S)-2-aminopropanoic acid
147245-92-9
AC1MIXQC
Aventis brand of copolymer 1
C089995
CID3081884
COP-1
Copaxone
Copolymer 1
 
Copolymer-1
Copoylmer 1
Glatiramer acetate
Glatiramer acetate [USAN]
L-Glutamic acid peptide with L-alanine, L-lysine and L-tyrosine, acetate (salt)
L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt)
LS-186971
LS-71889
TV 5010
TV-5010
TV5010
Teva brand of copolymer 1
UNII-5M691HL4BO
acetic acid
20Immunosuppressive AgentsPhase 210422
21Immunologic FactorsPhase 218483
22Adjuvants, ImmunologicPhase 21783
23
Adalimumabapproved443331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
24
methylene blue71
Synonyms:
Urolene Blue
aniline violet
 
methylthionine chloride
methylthioninium chloride
methylthioninium chloride Proveblue
tetrametylthionine chloride
25Tolonium Chloride8
26Pharmaceutical Solutions7004
27
Bismuth1037440-69-916682734, 105143
Synonyms:
17034_FLUKA
24267-48-9
25243-76-9
264008_ALDRICH
265462_ALDRICH
265470_ALDRICH
452386_ALDRICH
556130_ALDRICH
7440-69-9
83Bi
95372_ALDRICH
95372_FLUKA
95375_FLUKA
AC1NSDYX
AC1O4PN8
AR-1I0647
BISMUTH, 99.95%
 
BISMUTH, 99.999%
Bi
Bismut
Bismuth standard for AAS
Bismuth standard for ICP
Bismuth(III) nitrate solution
Bismuth, elemental
Bismuth-209
C15471
CHEBI:33301
CID5359367
EINECS 231-177-4
HSDB 2078
LS-44708
LTBB002773
MolPort-003-925-759
Wismut
bismuth
bismuto
28Anti-Ulcer Agents1453
29Antacids1453
30ColaNutraceutical1768

Interventional clinical trials:

(show all 26)
idNameStatusNCT IDPhase
1Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative ColitisCompletedNCT01408810Phase 4
2Trial of Mesalamine for the Treatment of Active Microscopic ColitisCompletedNCT00952952Phase 2, Phase 3
3Budesonide Treatment for Lymphocytic ColitisCompletedNCT00180050Phase 3
4Budesonide for Maintenance Treatment of Collagenous ColitisCompletedNCT00180076Phase 3
5SOIBD Collagenous Colitis Maintenance StudyCompletedNCT01278082Phase 3
6Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous ColitisCompletedNCT00450086Phase 3
7Budesonide for Induction of Remission in Incomplete Microscopic ColitisRecruitingNCT02142634Phase 3
8Budesonide Versus Mesalazine Versus Placebo in Lymphocytic ColitisRecruitingNCT01209208Phase 3
9Long-Term Treatment of Collagenous Colitis With BudesonideActive, not recruitingNCT00139165Phase 3
10Budesonide Versus Placebo for the Treatment of Lymphocytic ColitisTerminatedNCT00217022Phase 2, Phase 3
11A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's DiseaseRecruitingNCT00731172Phase 2
12Confocal Laser Endomicroscopy Findings in Patients With Proctosigmoiditis Before and After Initiation of TreatmentCompletedNCT01684514
13Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)CompletedNCT01289366
14Usefulness of Chromoendoscopy in Diagnosing Microscopic ColitisRecruitingNCT01504048
15Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS)RecruitingNCT01787253
16Ussing Experiments to Evaluate the Role of Medication-induced Microscopic ColitisRecruitingNCT02303132
17Early Detection of Tumors of the Digestive Tract by Confocal EndomicroscopyRecruitingNCT02284802
18Fecal Microbiota Transplantation for C Diff InfectionRecruitingNCT01905709
19Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative ColitisRecruitingNCT02676817
20OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the AgesRecruitingNCT02523118
21The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel DiseaseRecruitingNCT02481687
22Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)RecruitingNCT02049775
23Changes in Stem Cells of the Colon in Response to Increased Risk of Colorectal CancerActive, not recruitingNCT01075893
24Case-Control Study to Identify Risk Factors for Microscopic ColitisEnrolling by invitationNCT01928667
25Risk Factors for Microscopic ColitisNot yet recruitingNCT02699333
26Treatment of Microscopic ColitisTerminatedNCT00184171

Search NIH Clinical Center for Microscopic Colitis


Cochrane evidence based reviews: colitis, microscopic

Genetic Tests for Microscopic Colitis

About this section

Anatomical Context for Microscopic Colitis

About this section

MalaCards organs/tissues related to Microscopic Colitis:

33
Colon, Lung, Liver, Brain, Breast, Bone, Prostate

Animal Models for Microscopic Colitis or affiliated genes

About this section

MGI Mouse Phenotypes related to Microscopic Colitis:

38 (show all 13)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.2CD79A, IFNG, IL4, IL6, LYZ
2MP:00020068.1CD79A, IFNG, IL2, IL6, LYZ, TNF
3MP:00030127.9CD79A, IFNG, IL2, IL4, LYZ, TNF
4MP:00107717.9IFNG, IL4, IL6, LYZ, SLC6A4, TNF
5MP:00053707.7IFNG, IL2, IL4, IL6, LYZ, TNF
6MP:00053887.7IFNG, IL2, IL4, IL6, LYZ, TNF
7MP:00053817.6IFNG, IL2, IL4, IL6, LYZ, TNF
8MP:00036317.5CD79A, IFNG, IL4, IL6, LYZ, SLC6A4
9MP:00053797.4IFNG, IL2, IL4, IL6, LYZ, SLC6A4
10MP:00053766.9CD79A, IFNG, IL2, IL4, IL6, LYZ
11MP:00053876.7CD79A, IFNG, IL2, IL4, IL6, LYZ
12MP:00053976.6CD79A, IFNG, IL2, IL4, IL6, LYZ

Publications for Microscopic Colitis

About this section

Articles related to Microscopic Colitis:

(show top 50)    (show all 267)
idTitleAuthorsYear
1
Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. (25483452)
2015
2
Central role of ULK1 in type I interferon signaling. (25892232)
2015
3
Diversity in the Strength and Structure of Unruptured Cerebral Aneurysms. (25632891)
2015
4
Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications. (24677602)
2014
5
Three intragenic suppressors of a GTPase-deficient allele of GNAS associated with McCune-Albright syndrome. (24850831)
2014
6
Management of non-inflammatory locally advanced breast cancer: focus on surgical approaches. (24382437)
2013
7
Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. (24037726)
2013
8
Ocular candidiasis complicated by branch retinal vein occlusion. (23335209)
2013
9
Vaginal fistula in a patient with relapsed ovarian cancer and amelanotic melanoma. (22593454)
2012
10
Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors: evidence for the role of c-Jun N-terminal kinase activation. (22895172)
2012
11
Fibrillin-1 genotype and risk of prevalent hypertension: a study in two independent populations. (22545955)
2012
12
Mass measles vaccination. (23115458)
2012
13
Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. (19889173)
2011
14
p53-independent induction of G1 arrest and p21WAF1/CIP1 expression by ascofuranone, an isoprenoid antibiotic, through downregulation of c-Myc. (20587660)
2010
15
Effectiveness of ezetimibe in improving lipid goal attainment in patients with coronary heart diseases treated with statin]. (19957635)
2009
16
Expression of Livin in laryngeal squamous cell carcinoma and relationship with bFGF]. (18476630)
2008
17
Phylogenetic conservation of glycoprotein 96 ability to interact with CD91 and facilitate antigen cross-presentation. (18292541)
2008
18
Inhibitory effect of carnosine on interleukin-8 production in intestinal epithelial cells through translational regulation. (18397832)
2008
19
Cytodiagnosis of supratentorial hemangioblastoma. (18500008)
2008
20
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study. (18509006)
2008
21
Ten novel RB1 gene mutations in patients with retinoblastoma. (17960112)
2007
22
Nuclear import and retention domains in the amino terminus of RECQL4. (17250975)
2007
23
Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cells. (17509725)
2007
24
GnRH and GnRH receptors in metazoa: a historical, comparative, and evolutive perspective. (17350014)
2007
25
Pentaspan membrane glycoprotein, prominin-1, is involved in glucose metabolism and cytoskeleton alteration. (17922643)
2007
26
The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling. (17041096)
2006
27
Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia. (16635071)
2006
28
Regulation of c-fos and c-jun gene expression by lipopolysaccharide and cytokines in primary cultured astrocytes: effect of PKA and PKC pathways. (15180304)
2004
29
Pathophysiology and treatment of obesity hypertension. (15579059)
2004
30
Counter-regulatory balance: atopic dermatitis in patients undergoing infliximab infusion therapy. (15176169)
2004
31
Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis. (14627700)
2004
32
Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review. (14615409)
2003
33
Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. (13679428)
2003
34
Expression of the duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium. (12081195)
2002
35
Hormonal regulation of mammary differentiation and milk secretion. (12160086)
2002
36
Comparison of brain perfusion SPECT and MRI findings in children with neuronal ceroid-lipofuscinosis and in their families. (12126045)
2002
37
Mitochondrial myopathy and ophthalmoplegia in a sporadic patient with the G12315A mutation in mitochondrial DNA. (12398839)
2002
38
Identification of a novel HLA-B allele--HLA-B*4902. (11260516)
2001
39
Hemicrania continua is not that rare. (11577748)
2001
40
Properties of recombinant HtrA: an otitis media vaccine candidate antigen from non-typeable Haemophilus influenzae. (11214237)
2000
41
An immunohistochemical study of the steroid hormone receptors in endometrial hyperplasia]. (10756900)
1999
42
Histidine-rich glycoprotein prevents the formation of insoluble immune complexes by rheumatoid factor. (10583608)
1999
43
Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes. (9468218)
1998
44
Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway. (9582321)
1998
45
Long-term outcome of patients treated for hydrocele with the sclerosant agent sodium tetradecyl sulphate. (8738055)
1996
46
Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. (8188246)
1994
47
The histologic, ultrastructural, and immunohistochemical features of a blastema-predominant canine nephroblastoma. (1320304)
1992
48
Gene sequence, developmental expression, and protein phosphorylation of RAB-17 in maize. (2151715)
1990
49
Yellow nail syndrome with bilateral bronchiectasis. (5933134)
1966
50

Variations for Microscopic Colitis

About this section

Expression for genes affiliated with Microscopic Colitis

About this section
Search GEO for disease gene expression data for Microscopic Colitis.

Pathways for genes affiliated with Microscopic Colitis

About this section

Pathways related to Microscopic Colitis according to GeneCards Suite gene sharing:

(show all 41)
idSuper pathwaysScoreTop Affiliating Genes
19.3IL4, IL6
29.3IL6, SLC6A4, TNF
39.0IL4, IL6, TNF
48.8IFNG, IL6, TNF
58.8IFNG, IL6, TNF
68.8IFNG, IL6, TNF
78.8IFNG, IL6, TNF
8
Show member pathways
8.8IFNG, IL6, TNF
98.8IFNG, IL6, TNF
10
Show member pathways
8.8IFNG, IL2, TNF
11
Show member pathways
8.8IFNG, IL2, TNF
128.8HLA-DRB1, IFNG, IL2
138.7HLA-DRB1, IL2, IL6, TNF
148.6HLA-DRB1, IL4, IL6, TNF
158.6IFNG, IL2, IL6
16
Show member pathways
8.5IFNG, IL4, IL6
178.5IFNG, IL2, IL4
188.5IFNG, IL2, IL4
198.5IFNG, IL2, IL4
208.4HLA-DRB1, IFNG, IL6, TNF
218.4HLA-DRB1, IFNG, IL6, TNF
22
Show member pathways
8.3HLA-DRB1, IFNG, IL4, TNF
23
Show member pathways
8.3IFNG, IL2, IL6, TNF
248.3IFNG, IL2, IL6, TNF
25
Show member pathways
8.3IFNG, IL2, IL6, TNF
268.3IFNG, IL2, IL6, TNF
27
Show member pathways
8.2IFNG, IL4, IL6, TNF
28
Show member pathways
8.2IFNG, IL2, IL4, TNF
29
Show member pathways
8.2IFNG, IL2, IL4, TNF
308.2IFNG, IL2, IL4, TNF
31
Show member pathways
8.1HLA-DRB1, IFNG, IL2, IL4
328.0IFNG, IL2, IL4, IL6
33
Show member pathways
8.0IFNG, IL2, IL4, IL6
34
Show member pathways
7.7IFNG, IL2, IL4, IL6, TNF
357.7IFNG, IL2, IL4, IL6, TNF
36
Show member pathways
7.5CD79A, HLA-DRB1, IFNG, IL2, IL4, TNF
37
Show member pathways
7.4CD79A, HLA-DRB1, IFNG, IL2, IL4, TNF
387.4CD79A, IFNG, IL2, IL4, IL6, TNF
39
Show member pathways
7.3HLA-DRB1, IFNG, IL2, IL4, IL6, TNF
407.3HLA-DRB1, IFNG, IL2, IL4, IL6, TNF
41
Show member pathways
7.3HLA-DRB1, IFNG, IL2, IL4, IL6, TNF

GO Terms for genes affiliated with Microscopic Colitis

About this section

Biological processes related to Microscopic Colitis according to GeneCards Suite gene sharing:

(show all 32)
idNameGO IDScoreTop Affiliating Genes
1epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.3IL6, TNF
2positive regulation of nitric oxide biosynthetic processGO:004542910.3IL6, TNF
3positive regulation of mononuclear cell migrationGO:007167710.2IL4, TNF
4negative regulation of lipid storageGO:001088810.2IL6, TNF
5negative regulation of fat cell differentiationGO:004559910.2IL6, TNF
6positive regulation of calcidiol 1-monooxygenase activityGO:006055910.0IFNG, TNF
7positive regulation of membrane protein ectodomain proteolysisGO:005104410.0IFNG, TNF
8positive regulation of B cell activationGO:005087110.0IL4, IL6
9positive regulation of T cell differentiationGO:004558210.0IL2, IL4
10extrinsic apoptotic signaling pathway in absence of ligandGO:00971929.9IL2, IL4
11positive regulation of tyrosine phosphorylation of Stat5 proteinGO:00425239.9IL2, IL4
12positive regulation of B cell proliferationGO:00308909.9IL2, IL4
13negative regulation of growth of symbiont in hostGO:00441309.9IFNG, TNF
14neutrophil apoptotic processGO:00017819.9IFNG, IL6
15antigen processing and presentationGO:00198829.8HLA-DRB1, IFNG
16protein import into nucleus, translocationGO:00000609.8IFNG, TNF
17positive regulation of osteoclast differentiationGO:00456729.7IFNG, TNF
18positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.5IL4, IL6, TNF
19positive regulation of MHC class II biosynthetic processGO:00453489.4IFNG, IL4
20positive regulation of chemokine biosynthetic processGO:00450809.4IFNG, IL4, TNF
21positive regulation of protein phosphorylationGO:00019349.3IL2, IL4, TNF
22cytokine-mediated signaling pathwayGO:00192219.2HLA-DRB1, IFNG, IL6
23adaptive immune responseGO:00022509.2CD79A, IFNG, IL2
24defense response to protozoanGO:00428329.1IFNG, IL4, IL6
25positive regulation of T cell proliferationGO:00421029.1IFNG, IL2, IL4
26positive regulation of isotype switching to IgG isotypesGO:00483049.0IFNG, IL2, IL4
27cellular response to lipopolysaccharideGO:00712228.8IFNG, IL6, TNF
28positive regulation of transcription, DNA-templatedGO:00458938.6IFNG, IL4, IL6, TNF
29response to drugGO:00424938.3IFNG, IL4, IL6, SLC6A4
30positive regulation of cell proliferationGO:00082847.9IFNG, IL2, IL4, IL6
31positive regulation of transcription from RNA polymerase II promoterGO:00459447.7IFNG, IL2, IL4, IL6, TNF
32immune responseGO:00069556.9HLA-DRB1, IFNG, IL2, IL4, IL6, MR1

Sources for Microscopic Colitis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet